MIXED CHIMERISM AS AN APPROACH FOR THE INDUCTION OF TRANSPLANTATION TOLERANCE1
TGF-β QUANTITATION CAN BE TRICKY
UNDERSTANDING "MARGINAL" LIVER GRAFTS
TECHNICAL-VARIANT LIVER GRAFTS IN PEDIATRIC LIVER TRANSPLANTATION: BACK TO THE FUTURE
ALLELE-SPECIFIC AND PEPTIDE-DEPENDENT RECOGNITION OF SWINE LEUKOCYTE ANTIGEN CLASS I BY HUMAN CYTOTOXIC T-CELL CLONES1
COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISM
THE EFFECT OF THYMECTOMY ON TOLERANCE INDUCTION AND CARDIAC ALLOGRAFT VASCULOPATHY IN A MINIATURE SWINE HEART/KIDNEY TRANSPLANTATION MODEL1,2
THE INFLUENCE OF COMBINED TROPHIC FACTORS ON THE SUCCESS OF FETAL PANCREAS GRAFTS1
LAPAROSCOPIC VERSUS OPEN DONOR NEPHRECTOMY
THE CLINICAL IMPORTANCE OF CHOOSING THE RIGHT ASSAY FOR DETECTION OF HLA-SPECIFIC DONOR-REACTIVE ANTIBODIES1
ATTITUDES OF PATIENTS BEFORE AND AFTER TRANSPLANTATION TOWARDS VARIOUS ALLOGRAFTS1
THE INFLUENCE OF HISTOCOMPATIBILITY ON GRAFT REJECTION AND GRAFT SURVIVAL WITHIN A SINGLE CENTER POPULATION OF HEART TRANSPLANT RECIPIENTS
CAN HEPATITIS B CORE ANTIBODY POSITIVE LIVERS BE USED SAFELY FOR TRANSPLANTATION: HEPATITIS B VIRUS DETECTION IN THE LIVER OF INDIVIDUALS WHO ARE HEPATITIS B CORE ANTIBODY POSITIVE
PREVENTION OF OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATION
POOR OUTCOME IN PATIENTS WITH DIABETES MELLITUS UNDERGOING LIVER TRANSPLANTATION.
INCREASED INCIDENCE OF POSTOPERATIVE INFECTIONS ASSOCIATED WITH PERITONEAL DIALYSIS IN RENAL TRANSPLANT RECIPIENTS
ANALYSIS OF SURVIVAL AND MORBIDITY AFTER PEDIATRIC LIVER TRANSPLANTATION WITH FULL-SIZE AND TECHNICAL-VARIANT GRAFTS
A HUMANIZED ANTI-CD3 ANTIBODY, HuM291, WITH LOW MITOGENIC ACTIVITY, MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES
PATTERNS OF IMMUNE RESPONSES EVOKED BY ALLOGENEIC HEPATOCYTES
HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1
USE OF OCTOGENARIAN LIVERS SAFELY EXPANDS THE DONOR POOL
HETEROZYGOUS PROTHROMBIN GENE MUTATION: A NEW RISK FACTOR FOR EARLY RENAL ALLOGRAFT THROMBOSIS
CLEAR BENEFIT OF MYCOPHENOLATE MOFETIL-BASED TRIPLE THERAPY IN REDUCING THE INCIDENCE OF ACUTE REJECTION AFTER LIVING DONOR RENAL TRANSPLANTATIONS1,2
LAPAROSCOPIC LIVING DONOR NEPHRECTOMY
BLOOD LEVELS OF TGFβ1 IN LIVER TRANSPLANT RECIPIENTS RECEIVING EITHER TACROLIMUS OR MICRO-EMULSIFIED CYCLOSPORINE
ANALYSIS OF VARIABLE REGION OF T-CELL RECEPTOR β CHAIN USAGE IN THE HUMAN ANTI-PORCINE XENORESPONSE1
REPEAT DONOR HLA-DR MISMATCHES IN RENAL TRANSPLANTATION: IS THE INCREASED FAILURE RATE CAUSED BY NONCYTOTOXIC HLA-DR ALLOANTIBODIES?
LETTERS TO THE EDITOR
LETTERS TO THE EDITOR
ANNOUNCEMENTS